Multiple myeloma (MM) is a plasma cell neoplasm and constitutes 10% of hematologic malignancies. Malignant myelomatous pleural effusions are very rare and occur in <1% of cases of MM. In this article, we report a rare case of a patient who initially presented with pleural effusion and was subsequently found to be secondary to MM with an underlying raised IgG paraprotein. The patient symptomatically improved and was in partial remission with palliative radiotherapy, VTD chemotherapy, and bisphosphonates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351363 | PMC |
| http://dx.doi.org/10.4103/0970-2113.201318 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Myelomatous pleural effusion (MPE) is a rare, often treatment-resistant complication of multiple myeloma. Intrapleural bortezomib shows promise but lacks standardized dosing. We report a 62-year-old woman with MPE treated with 1.
View Article and Find Full Text PDFBilateral myelomatous pleural effusions: an unusual presentation in newly diagnosed multiple myeloma.
BMJ Case Rep
June 2024
Oncology, Mount Sinai Hospital, Chicago, Illinois, USA.
Multiple myeloma is a rare haematological malignancy characterised by the clonal proliferation of plasma cells within the bone marrow. Typical manifestations include bone pain, fatigue and monoclonal protein elevation in serum and urine. Less than 1% of cases develop myelomatous pleural effusion, a severe complication indicative of advanced disease and a very poor prognosis.
View Article and Find Full Text PDFCase Report: A very rare case of a Pleural Effusion revealing Multiple Myeloma.
F1000Res
May 2024
Faculty of Medicine, University of Tunis El Manar, Tunis, 1007, Tunisia.
Multiple myeloma is a common malignant bone-based disease. Pleural effusions reported in these patients remain rare. It is commonly due to congestive heart disease, pulmonary embolism, nephrotic syndrome or a second neoplasia.
View Article and Find Full Text PDFMyelomatous pleural effusion in multiple myeloma- A rare presentation.
J Cancer Res Ther
January 2024
Department of Pathology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.
Article Synopsis
- * A case report highlights a 41-year-old patient experiencing bilateral pleural effusion during a relapse of multiple myeloma, treated with a chemotherapy regimen that included cyclophosphamide, bortezomib, and dexamethasone.
- * Despite an initial positive response to treatment, the patient's condition deteriorated, leading to a poor prognosis and eventual death, underscoring the need for early diagnosis and treatment to potentially enhance outcomes in similar cases.
Multiple Myeloma: A Rare Presentation As Unilateral Pleural Effusion.
Cureus
February 2024
Microbiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of plasma cells in the bone marrow. It commonly presents with bone pain, anemia, renal failure, and hypercalcemia. Pleural effusion in MM usually has multiple causes, but it is rare for the effusion to be due to myelomatous deposition of the pleura.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!